QCG
MGNX icon

Quadrant Capital Group’s MacroGenics MGNX Stock Holding History

Quadrant Capital Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-79
Closed -$567 – 2740
2023
Q1 		$567 Sell
79
-198
-71% -$1.19K ﹤0.01% 2592
2022
Q4 		$1.86K Buy
+277
New +$1.52K ﹤0.01% 2435
2022
Q2 		– Sell
-29
Closed – – 2658
2022
Q1 		$0 Buy
+29
New +$320 ﹤0.01% 2617
2019
Q3 		– Sell
-3,955
Closed -$66K – 2354
2019
Q2 		$66K Buy
+3,955
New +$67.9K 0.01% 1077

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Quadrant Capital Group's MGNX Position: Q2 2023 in Review

Quadrant Capital Group sold out of MacroGenics (MGNX) in Q2 2023, closing a stake of 79 shares — an estimated $567 sold.

Quadrant Capital Group first reported a position in MGNX in Q2 2019 and held it in 4 quarters. The position peaked at $66K in Q2 2019. 131 funds tracked by Wall St. Rank hold MGNX as of Q2 2023.

  • Quadrant Capital Group reported no remaining MacroGenics position as of Q2 2023 after selling out during the quarter.
  • Quadrant Capital Group sold 79 MacroGenics shares in Q2 2023, an estimated $567.
  • Quadrant Capital Group first reported a position in MacroGenics in Q2 2019 and held it in 4 quarters.
  • Quadrant Capital Group's MacroGenics position peaked at $66K in Q2 2019.
  • 131 funds tracked by Wall St. Rank held MacroGenics as of Q2 2023.

Based on Quadrant Capital Group's 13F filing for Q2 2023, filed 10 Aug 2023.